Uveitis drugs in development, 2023

GlobalData tracks 85 drugs in development for Uveitis by 77 companies/universities/institutes. The top development phase for Uveitis is preclinical, with 51 drugs in that stage.

FDA expands import alert to block all plastic syringes from Chinese manufacturer

Dive Brief: The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering

April 11, 2024

CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting – Biotech Investments

Issuer: CureVac / Key word(s): Conference 28.10.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac to Present at

October 29, 2024

Researchers Hit the Road to Learn Why CVD and COPD Are Rampant in the Rural South

Darrell Dixon’s father was just 25 when he had a major heart attack in the rural Mississippi Delta. By his early 40s, a series of

August 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.